Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
VCYT compared with TWST: revenue, margins and what each company keeps, and the suppliers and customers both name
VCYT
Veracyte, Inc.
Change
Mkt cap
Revenue
Revenue
TWST
Twist Bioscience Corp
Change
Mkt cap
Revenue
Revenue
vs
Compare
VCYT
Veracyte, Inc.
vs
TWST
Twist Bioscience Corp
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
Supply-chain overlap
Revenue flow
TWST: latest quarter is a loss; flow not drawable.
Method
›
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only VCYT
9
UNH
UnitedHealthcare
customer
BRKR
NanoString (now Bruker Spatial Biology as a result of Bruker Corporation's asset acquisition of NanoString)
supplier
—
Silicon Valley Bank
unlisted
supplier
—
Medicare
unlisted
customer
5 more · VCYT chain
›
Shared
0
No shared counterparties.
Only TWST
15
GRAL
Grail
customer
WGS
GeneDx
customer
DNA
Ginkgo Bioworks
customer
IBIO
iBio
customer
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
11 more · TWST chain
›
VCYT
Veracyte, Inc.
Change
50.01
▼
−4.14%
· post 49.60
Mkt cap
$4.0B
Revenue
$150M
Q2 FY26
Revenue
$517M
FY25
TWST
Twist Bioscience Corp
Change
153.04
▼
−11.77%
· post 152.02
Closed
Oct 30 '26
Mkt cap
$9.6B
Revenue
$118M
Q3 FY26
Revenue
$377M
FY25
vs
Compare
Closed
Oct 30 '26
VCYT
Veracyte, Inc.
vs
TWST
Twist Bioscience Corp
50.01
▼
−4.14%
post 49.60
Price
153.04
▼
−11.77%
post 152.02
$4.0B
Mkt cap
$9.6B
Q2 FY26
$150M
Revenue
$118M
Q3 FY26
FY25
$517M
Revenue
$377M
FY25
Change
Change
VCYT
50.01
▼
−4.14%
vs
TWST
153.04
▼
−11.77%
Closed
Oct 30 '26
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
VCYT, solid
TWST, dashed